These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 203056)

  • 1. Adenylate cyclase and phosphodiesterase activity in the platelet release abnormality.
    Chesney CM; Baker AS; Carvalho AC; Ozer A; Meissner GF; Colman RW
    Thromb Haemost; 1977 Dec; 38(4):971-83. PubMed ID: 203056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F; Vulliemoz Y; Verosky Y; Triner L
    Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M
    Cell Biochem Funct; 1991 Apr; 9(2):79-85. PubMed ID: 1718622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term changes in levels of cyclic AMP, adenylate cyclase, and phosphodiesterase during the initiation of sperm motility in rainbow trout.
    Morisawa M; Ishida K
    J Exp Zool; 1987 May; 242(2):199-204. PubMed ID: 3039036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low environmental temperature on adenylate cyclase and phosphodiesterase in rat tissues.
    Sarkar SR; Singh LR; Chaudhuri BN
    Acta Biol Med Ger; 1982; 41(10):967-9. PubMed ID: 6303027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
    Jackson BA; Edwards RM; Valtin H; Dousa TP
    J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenylate cyclase and phosphodiesterase activity in rabbit ureter.
    Weiss RM; Vulliemoz Y; Verosky M; Rosen MR; Triner L
    Invest Urol; 1977 Jul; 15(1):15-8. PubMed ID: 194862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
    Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
    Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
    Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
    Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the adenylate cyclase activity of the lymphocytes and thrombocytes in irradiated sheep].
    Shevchenko AS
    Radiobiologiia; 1990; 30(3):308-11. PubMed ID: 2164696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.